Skip to content
Tuesday, March 28, 2023
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending
SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
BIOTCHNO Featured 

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

April 1, 2021August 4, 2021 RJ
LaunchLife International Announces the Relaunch of Student Tutoring APP tutit
BIOTCHNO Featured 

LaunchLife International Announces the Relaunch of Student Tutoring APP tutit

February 11, 2021April 8, 2021 Bachittar
Amgen announces Artificial Intelligence (AI) Partnership with Mila
BIOTCHNO Trending 

Amgen announces Artificial Intelligence (AI) Partnership with Mila

March 16, 2021July 19, 2021 Raza
FACIT Crowns 2021 Winner of Falcons’ Fortunes Pitch Competition; Announces Follow-on Investment in 2020 Winner, Bridge7 Oncology
BIOTCHNO Trending 

FACIT Crowns 2021 Winner of Falcons’ Fortunes Pitch Competition; Announces Follow-on Investment in 2020 Winner, Bridge7 Oncology

February 4, 2021April 16, 2021 Desiree Justice
The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition
BIOTCHNO Trending 

The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition

December 23, 2020April 16, 2021 vanessa
Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)
BIOTCHNO Trending 

Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)

December 15, 2020May 24, 2021 vanessa

General

Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
BIOTCHNO General 

Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry

March 22, 2021June 2, 2021 Raza

Canada NewsWire BEIJING , March 22, 2021 /CNW/ — Nanjing Jiangbei New Area , a state-level new area in east

AmpliTech Group, Inc. Expands Board of Directors Announcing Second New Board Member
BIOTCHNO General 

AmpliTech Group, Inc. Expands Board of Directors Announcing Second New Board Member

February 28, 2021April 8, 2021 vanessa
UAT Group Acquires Boost Words, Inc.
BIOTCHNO General 

UAT Group Acquires Boost Words, Inc.

February 23, 2021April 8, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO General 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 16, 2021 Bachittar
BioVaxys Announces Appointment of Corporate Advisor
BIOTCHNO General 

BioVaxys Announces Appointment of Corporate Advisor

February 12, 2021April 16, 2021 Bachittar

Financing

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering
BIOTCHNO Financing 

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering

February 19, 2021April 8, 2021 Bachittar

Bohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020
BIOTCHNO Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 16, 2021 Bachittar
Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club
BIOTCHNO Financing 

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

February 18, 2021April 16, 2021 Bachittar
ESSA Pharma Announces Pricing of Public Offering of Common Shares
BIOTCHNO Financing 

ESSA Pharma Announces Pricing of Public Offering of Common Shares

February 17, 2021April 16, 2021 Bachittar

Global

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant
BIOTCHNO Global 

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant

March 1, 2021May 17, 2021 Raza

Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
BIOTCHNO Global 

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

February 11, 2021April 8, 2021 Bachittar
Olympus launches comprehensive global educational platform for healthcare professionals
BIOTCHNO Global 

Olympus launches comprehensive global educational platform for healthcare professionals

January 31, 2021April 8, 2021 vanessa

Pharma

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
BIOTCHNO Pharma 

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

May 24, 2021June 7, 2021 Raza

Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
BIOTCHNO Pharma 

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

March 30, 2021July 26, 2021 Raza
Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts
BIOTCHNO Pharma 

Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts

December 7, 2020April 8, 2021 vanessa
enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer
BIOTCHNO Pharma 

enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer

December 3, 2020April 16, 2021 vanessa
Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
BIOTCHNO Pharma 

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

November 30, 2020April 8, 2021 vanessa

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479